Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin

British Journal of Pharmacology

Volumn 130, Issue 2, 2000, Pages 425-433

  Sbrenna, S ^a   Marti, M ^a   Morari, M ^a   Calo', G ^a   Guerrini, R ^a   Beani, L ^a   Bianchi, C ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

5 hydroxytryptamine; Nociceptin; Opioid receptors; Rat cerebral cortex; Synaptosomes

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN; NORBINALTORPHIMINE; OPIATE; OPIATE RECEPTOR; POTASSIUM; PRESYNAPTIC RECEPTOR; SEROTONIN; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

EID: 0034023913     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703321     Document Type: Article

References (58)

1. BRADBURY, A.F., AND SMYTHE, D.G. & SNELL, C.R. (1976). C fragment lipotropin has high affinity for brain opiate receptors. Nature, 260, 282-288.
2. BUNZOW, J.R., SAEZ, C., MORTRUD, M., BOUVIER, C., WILLIAMS, J.T., LOW, M. & GRANDY, D.K. (1994). Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett., 347, 284-288.
3. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J. Med. Chem., 41, 3360-3366.
4. 2, a new selective nociceptin receptor antagonist. Br. J. Pharmacol., 129, 1183-1193.
5. CALO, G., RIZZI, A., MARZOLA, G., GUERRINI, R., SALVADORI, S., BEANI, L., REGOLI, D. & BIANCHI, C. (1998b). Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol., 125, 373-378.
6. 2, a peripheral ORL 1 receptor antagonist, acts as an agonist in the rat spinal cord. Br. J. Pharmacol., 125, 949-950.
7. COLLARD, K.J., CASSIDY, D.M., PYE, M.A. & TAYLOR, R.M. (1981). The stimulus-induced release of unmetabolized 5-hydroxytryptamine from superfused rat brain synaptosomes. J. Neurosci. Meth., 4, 163-179.
8. DHAWAN, B.N., CESSELIN, F., RAUGHUBIR, R., REISINE, T., BRADLEY, P.B., PORTOGHESE, P.S. & HAMON, M. (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567-592.
9. DRIESSEN, B. & REIMANN, W. (1992). Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br. J. Pharmacol., 105, 147-151.
10. DUNNILL, R.J., KAKIZAWA, K., MCKNIGHT, A.T. & HENDERSON, G. (1996). Characterization of the actions of naloxone benzoylhydrazone at mu-opioid, kappa-opioid and ORL1 receptors in isolated tissues from rat and guinea-pig. Br. J. Pharmacol., 119, 275P.
11. ERSPAMER, V., MELCHIORRI, P., FALCONIERI-ERSPAMER, G., NEGRI, L. & CORSI, R. (1989). Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc. Natl. Acad. Sci. U.S.A., 86, 5188-5192.
12. GISTRAK, M.A., PAUL, D., HAHN, E.F. & PASTERNAK, G.W. (1989). Pharmacological actions of a novel mixed opiate agonist/ antagonist: naloxone benzoylhydrazone. J. Pharmacol. Exp. Ther., 251, 469-476.
13. GOLDSTEIN, A., TACHIBANA, S., LOWNEY, L.I., HUNKAPILLER, M. & HOOD, L. (1979). Dynorphin-(1-13), an extraordinary potent opioid peptide. Proc. Nat. Acad. Sci. U.S.A., 76, 6666-6670.
14. GUERRINI, R., CALO, G., RIZZI, A., BIGONI, R., BIANCHI, C., SALVADORI, S. & REGOLI, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163-165.
15. GUERRINI, R., CALO', G., BIGONI, R., VARANI, K., TOTH, G., GESSI, S., BOREA, P.A., SALVADORI, S. & REGOLI, D. (1999). Further studies on nociceptin related peptides: discovery of new molecules with antagonistic activity on the nociceptin receptor. Regul. Peptides, 80, 124.
16. HAGAN, R.M. & HUGHES, I.E. (1984). Opioid receptor sub-types involved in the control of transmitter release in cortex of the brain of the rat. Neuropharmacology, 23, 491-495.
17. 2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese ovary cells stably expressing the recombinant human nociceptin receptor. Neurosci. Lett., in press.
18. HUGES, J., SMITH, T.W., FOTHERGILL, L.A., MORGAN, B.A., MORRIS, H.R. & KOSTERLITZ, H.W. (1975). Identification of two related peptides from the brain with potent opiate agonist activity. Nature, 258, 577-579.
19. JENKINSON, D.H., BARNARD, E.A., HOYER, D., HUMPREY, P.P.A., LEFF, P. & SHANKLEY, N.P. (1995). International Union of Pharmacology Commitee on receptor nomenclature and drug classification XI Recommendations on terms and symbols in quantitative pharmacology. Pharmacol. Rev., 47, 255-266.
20. KAWAHARA, H., YOSHIDA, M., YOKOO, H., NISHI, M. & TANAKA, M. (1993). Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci. Lett., 162, 81-84.
21. KAYE, W.H. (1997). Persistent alterations in behaviour and serotonin activity after recovery from anorexia and bulimia nervosa. Ann. N.Y. Acad. Sci., 817, 162-178.
22. LEWIS, J.W., CANNON, J.T. & LIEBESKIND, J.C. (1980). Opioid and nonopioid mechanisms of stress analgesia. Science, 208, 623-625.
23. MANSOUR, A., FOX, C.A., AKIL, H. & WATSON, S.J. (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends. Neurosci., 18, 22-29.
24. MARKS, M.J., BULLOCK, A.E. & COLLINS, A.C. (1995). Sodium channel blockers partially inhibit nicotine-stimulated 86Rb +-efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther., 247, 833-841.
25. MAURA, G., GEMIGNANI, A., VERSACE, P., MARTIRE, M. & RAITERI, M. (1982). Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings. Neurochem. Int., 4, 219-224.
26. MEAGHER, M.W., GRAU, J.W. & KING, R.A. (1989). Frontal cortex lesions block the opioid and nonopioid hypoalgesia elicited by brief shocks but not the nonopioid hypoalgesia elicited by long shocks. Behav. Neurosci., 103, 1366-1371.
27. MERCER, M.E. & HOLDER, M.D. (1997). Food cravings, endogenous opioid peptides, and food intake: a review. Appetite, 29, 325-352.
28. MEUNIER, J.C. (1997). Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol., 340, 1-15.
29. MEUNIER, J.C., MOLLEREAU, C., TOLL, L., SUAUDEAU, C., MOISAND, C., ALVINERIE, P., BUTOUR, J.L., GUILLEMOT, J.C., FERRARA, P., MONSARRAT, B., MARZAGUIL, H., VASSART, G., PARMENTIER, M. & COSTENTIN, J., (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532-535.
30. MOINTELLET-AGIUS, G., FEIN, J., ANTON, B. & EVANS, C. (1998). ORL1 and Mu opioid receptor antisera label different fibers in areas involved in pain processing. J. Comp. Neurol., 399, 373-383.
31. MOLLEREAU, C., PARMENTIER, M., MAILLEUX, P., BUTOUR, J.L., MOISAND, C., CHALON, P., CAPUT, D., VASSART, G. & MEUNIER, J.C. (1994). ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS. Lett., 341, 33-38.
32. MONTIEL, J.L., CORNILLE, F., ROQUES, B.P & NOBLE, F. (1997). Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J. Neurochem., 68, 354-361.
33. MORARI, M., SBRENNA, S., MARTI, M., CALIARI, C., BIANCHI, C. & BEANI, L. (1998). NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre-and postsynaptic mechanisms. J. Neurochem., 71, 2006-2017.
34. MULDER, A.H., HOGENBOOM, F., WARDEH, G. & SCHOFFELMEER, A.N. (1987). Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu opioid receptors. J. Neurochem., 48, 1043-1047.
35. NICHOLSON, J.R., PATERSON, S.J., MENZIES, J.R.W., CORBETT, A.D. & MCKNIGHT, AT. (1998). Pharmacological studies on the 'orphan' opioid receptor in central and peripheral sites. Can. J. Physiol. Pharmacol., 76, 304-313.
36. NICOL, B., LAMBERT, D.G., ROWBOTHAM, D.J., SMART, D. & MCKNIGHT, A.T. (1996). Nociceptin induced inhibition of K + evoked glutamate release from rat cortical slices. Br. J. Pharmacol., 119, 1081-1083.
37. 2 in rat brain, rat vas deferens, and CHO cells expressing recombinant human nociceptin receptors. Br. J. Pharmacol, 127, 123-130.
38. PAN, Z.Z. (1998). Mu-opposing actions of the kappa-opioid receptor. Trends Pharmacol. Sci., 19, 94-98.
39. PASTERNAK, G.W. (1993). Pharmacological mechanisms of opioid analgesics. Clin Neurupharmacol., 16, 1-18.
40. PETTY, F., KRAMER, G. & WILSON, L. (1992). Prevention of learned helplessness: in vivo correlation with cortical serotonin. Pharmacol Biochem. Behav., 43, 361-367.
41. PINI, L.A., VITALE, G., OTTANI, A. & SANDRINI, M. (1997). Naloxone-reversible antinocicpetion in the rat. J. Pharmacol. Exp. Ther., 280, 934-940.
42. POLIDORI, C., CALO, G., CICCOCIOPPO, R., GUERRINI, R., REGOLI, D. & MASSI, M. (2000). Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology, 148, 430-437.
43. RAITERI, M., ANGELINI, F. & LEVI, G. (1974). A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol, 25, 411-414.
44. REINSCHEID, R.K., NOTHACKER, H.P., BOURSON, A., ARDATI, A., HENNINGSEN, R.A., BUNZOW, J R., GRANDY, D.K., LANGEN, H., MONSMA, JR., F.J. & CIVELLI, O. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 270, 792-794.
45. 2 antagonizes nociceptin effects in mouse colon. Eur. J. Pharmacol., 385, R3 R5.
46. SBRENNA, S., MARTI, M., MORARI, M., CALO, G., GUERRIN, R., BEANI, L. & BIANCHI, C. (1999a). L-glutamate and GABA efflux from rat cerebrocortical synaptosomes: modulation by kappa and mu, but not delta and ORL1 receptors. J. Pharmacol. Exp. Ther., 291, 1365-1371.
47. SBRENNA, S., MARTI, M., MORARI, M , CALO, G., GUERRINI, R., BEANI, L. & BIANCHI, C. (1999b). L-glutamate and γ-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by κ-and μ-but not δ-and opoid receptor like-1 receptors. Regul. Peptides, 80, 127.
48. SCHLICKER, E., WERTHWEIN, M., KATHMANN, M. & BAUER, U. (1998). Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's. Arch. Pharmacol, 358, 418-422.
49. SIMONATO, M. (1996). The neurochemistry of morphine addiction in the neocortex. Trends. Pharmacol. Sci., 17, 410-415.
50. SINISCALCHI, A., RODI, D., BEANI, L. & BIANCHI, C. (1999). Inhibitory effect of nociceptin on [3H]-5HT release from rat cerebral cortex slices. Br. J. Pharmacol, 128, 119-123.
51. + + and glutamate release. J. Neurochem., 53, 1693-1699.
52. TOLL, L., BURNSIDE, J. & BERZETEI-GURSKE, I. (1998). Agonist activity of ORL1 antagonists is dependent upon receptor number. International Narcotic Research Conference; http:// weber.u.washington.edu/~cchavkin/INRC/abstracts/A89.ht, A89.
53. TOOYAMA, I., ABE, H., RENDA, T., ERSPAMER, V. & KIMURA, H. (1993). [D-Ala2]Deltorphin I-like immunoreactivity in the adult rat brain: immunohistochemical localization. Proc. Natl. Acad. Sci., U.S.A., 90, 9635-9639.
54. VARANI, K., RIZZI, A., CALO, G., BIGONI, R., TOTH, G., GUERRINI, R., GESSI, S., SALVADORI, S., BOREA, P.A. & REGOLI, D. (1999). Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies. Naunyn-Schmiedeberg's Arch. Pharmacol, 360, 270-277.
55. VONVOIGTLANDER, P.F., LAHTI, R.A. & LUDENS, J.H. (1983). U-50, 488: a selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol. Exp. Ther., 224, 7-12.
56. WERTHWEIN, S., BAUER, U., NAKAZI, M., KATHMANN, M. & SCHLICKER, E. (1999). Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro. Br. J. Pharmacol, 127, 300-308.
57. + + into rat cortical synaptosomes by inhibiting N-but not L-type calcium channels. Neuropharmacology, 29, 439-444.
58. ZADINA, J.E., HACKLER, L., GE, L.J. & KASTIN, A.J. (1997). A potent and selective endogenous agonist of the mu-opiate receptor. Nature, 386, 499-502.